Insulatard Penfill

Insulin Human, the active ingredient in Insulatard Penfill, is an insulin presented as a pre‑filled pen for subcutaneous use. It is used to treat hyperglycaemia in people with type 1 diabetes mellitus and type 2 diabetes mellitus. Insulin Human works by replacing or supplementing the body’s natural insulin to help control blood glucose levels.

GNH USA supplies Insulatard Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulatard Penfill provides basal insulin therapy for diabetes management. - Type 1 diabetes mellitus: improves glycaemic control by supplying long‑acting insulin. - Type 2 diabetes mellitus: assists in achieving target fasting glucose levels when diet, exercise, or oral agents are insufficient. - Basal insulin therapy: offers steady insulin coverage to maintain fasting blood glucose between meals.

Common Side Effects: - Hypoglycaemia: low blood sugar episodes, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased appetite and caloric storage. - Lipodystrophy: localized thickening or thinning of subcutaneous fat. - Edema: mild fluid retention, often in the lower extremities. - Headache: transient mild headache.

Serious or Rare Side Effects: - Severe allergic reaction: urticaria, angioedema, or anaphylaxis. - Hypokalemia: low potassium levels, potentially causing cardiac arrhythmias. - Insulin‑induced lipohypertrophy: large areas of fat accumulation. - Acute respiratory distress: rare but serious breathing difficulty. - Persistent hypoglycaemia: prolonged low blood glucose requiring medical intervention. - Vision changes: transient blurred vision during hypoglycaemic episodes.

Before using Insulatard Penfill, consider the following precautions: - Hypoglycaemia risk: monitor blood glucose regularly and adjust dose as needed. - Renal impairment: use lower doses and monitor kidney function. - Hepatic impairment: may require dose adjustments. - Pregnancy and lactation: discuss benefits and risks with a healthcare professional. - Concomitant medications: review all drugs for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the pen.

Insulatard Penfill may interact with several medications. Major Interactions (Avoid): - Sulfonylureas or meglitinides: increased risk of severe hypoglycaemia. - Other insulin products: additive hypoglycaemic effect. - Beta‑adrenergic blockers: may mask hypoglycaemia symptoms. - MAO inhibitors: potential for unpredictable blood glucose changes. - Alcohol: can potentiate hypoglycaemia. Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose levels. - Corticosteroids: can increase insulin resistance. - Oral contraceptives: may alter insulin requirements. - ACE inhibitors: may enhance insulin sensitivity. - Lipid‑lowering agents (statins): possible modest effect on glucose control.